421 related articles for article (PubMed ID: 18640459)
1. Lipids, lipoproteins, and apolipoproteins as risk markers of myocardial infarction in 52 countries (the INTERHEART study): a case-control study.
McQueen MJ; Hawken S; Wang X; Ounpuu S; Sniderman A; Probstfield J; Steyn K; Sanderson JE; Hasani M; Volkova E; Kazmi K; Yusuf S;
Lancet; 2008 Jul; 372(9634):224-33. PubMed ID: 18640459
[TBL] [Abstract][Full Text] [Related]
2. Discordance analysis of apolipoprotein B and non-high density lipoprotein cholesterol as markers of cardiovascular risk in the INTERHEART study.
Sniderman AD; Islam S; Yusuf S; McQueen MJ
Atherosclerosis; 2012 Dec; 225(2):444-9. PubMed ID: 23068583
[TBL] [Abstract][Full Text] [Related]
3. High apolipoprotein B, low apolipoprotein A-I, and improvement in the prediction of fatal myocardial infarction (AMORIS study): a prospective study.
Walldius G; Jungner I; Holme I; Aastveit AH; Kolar W; Steiner E
Lancet; 2001 Dec; 358(9298):2026-33. PubMed ID: 11755609
[TBL] [Abstract][Full Text] [Related]
4. A prospective study of cholesterol, apolipoproteins, and the risk of myocardial infarction.
Stampfer MJ; Sacks FM; Salvini S; Willett WC; Hennekens CH
N Engl J Med; 1991 Aug; 325(6):373-81. PubMed ID: 2062328
[TBL] [Abstract][Full Text] [Related]
5. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study.
Yusuf S; Hawken S; Ounpuu S; Dans T; Avezum A; Lanas F; McQueen M; Budaj A; Pais P; Varigos J; Lisheng L;
Lancet; 2004 Sep 11-17; 364(9438):937-52. PubMed ID: 15364185
[TBL] [Abstract][Full Text] [Related]
6. Angiotensin-converting enzyme gene polymorphism, lipids, and apolipoproteins in menopausal women on hormone replacement therapy.
Cubrilo-Turek M; Sertić J; Duraković Z
Acta Med Croatica; 2001; 55(4-5):161-7. PubMed ID: 12398019
[TBL] [Abstract][Full Text] [Related]
7. [Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries in a case-control study based on the INTERHEART study].
Gyárfás I; Keltai M; Salim Y
Orv Hetil; 2006 Apr; 147(15):675-86. PubMed ID: 16734179
[TBL] [Abstract][Full Text] [Related]
8. Is the superiority of apoB over non-HDL-C as a marker of cardiovascular risk in the INTERHEART study due to confounding by related variables?
Sniderman AD; Islam S; Yusuf S; McQueen MJ
J Clin Lipidol; 2013; 7(6):626-31. PubMed ID: 24314360
[TBL] [Abstract][Full Text] [Related]
9. Computationally estimated apolipoproteins B and A1 in predicting cardiovascular risk.
Raitakari OT; Mäkinen VP; McQueen MJ; Niemi J; Juonala M; Jauhiainen M; Salomaa V; Hannuksela ML; Savolainen MJ; Kesäniemi YA; Kovanen PT; Sundvall J; Solakivi T; Loo BM; Marniemi J; Hernesniemi J; Lehtimäki T; Kähönen M; Peltonen M; Leiviskä J; Jula A; Anand SS; Miller R; Yusuf S; Viikari JS; Ala-Korpela M
Atherosclerosis; 2013 Jan; 226(1):245-51. PubMed ID: 23159013
[TBL] [Abstract][Full Text] [Related]
10. Association of risk factors with acute myocardial infarction in Middle Eastern countries: the INTERHEART Middle East study.
Gehani AA; Al-Hinai AT; Zubaid M; Almahmeed W; Hasani MR; Yusufali AH; Hassan MO; Lewis BS; Islam S; Rangarajan S; Yusuf S;
Eur J Prev Cardiol; 2014 Apr; 21(4):400-10. PubMed ID: 23125402
[TBL] [Abstract][Full Text] [Related]
11. Non-high density lipoprotein cholesterol is the best discriminator of myocardial infarction in young individuals.
Rallidis LS; Pitsavos C; Panagiotakos DB; Sinos L; Stefanadis C; Kremastinos DT
Atherosclerosis; 2005 Apr; 179(2):305-9. PubMed ID: 15777546
[TBL] [Abstract][Full Text] [Related]
12. Estradiol, testosterone, apolipoproteins, lipoprotein cholesterol, and lipolytic enzymes in men with premature myocardial infarction and angiographically assessed coronary occlusion.
Mendoza SG; Zerpa A; Carrasco H; Colmenares O; Rangel A; Gartside PS; Kashyap ML
Artery; 1983; 12(1):1-23. PubMed ID: 6431945
[TBL] [Abstract][Full Text] [Related]
13. Serum lipoproteins and apolipoproteins in young normocholesterolaemic, non-diabetic Indian men with myocardial infarction.
Sewdarsen M; Desai RK; Vythilingum S; Shah N; Rajput MC
Postgrad Med J; 1991 Feb; 67(784):159-64. PubMed ID: 2041847
[TBL] [Abstract][Full Text] [Related]
14. Role of lipid, apolipoprotein levels and apolipoprotein E genotype in young Italian patients with myocardial infarction.
Scaglione L; Bergerone S; Gambino R; Imazio M; Macchia G; Cravetto A; Gaschino G; Baralis G; Rosettani E; Pagano G; Cassader M
Nutr Metab Cardiovasc Dis; 1999 Jun; 9(3):118-24. PubMed ID: 10464784
[TBL] [Abstract][Full Text] [Related]
15. Errors that result from using the TC/HDL C ratio rather than the apoB/apoA-I ratio to identify the lipoprotein-related risk of vascular disease.
Sniderman AD; Jungner I; Holme I; Aastveit A; Walldius G
J Intern Med; 2006 May; 259(5):455-61. PubMed ID: 16629851
[TBL] [Abstract][Full Text] [Related]
16. Fasting and nonfasting lipid levels: influence of normal food intake on lipids, lipoproteins, apolipoproteins, and cardiovascular risk prediction.
Langsted A; Freiberg JJ; Nordestgaard BG
Circulation; 2008 Nov; 118(20):2047-56. PubMed ID: 18955664
[TBL] [Abstract][Full Text] [Related]
17. Chronic kidney disease, lipids and apolipoproteins, and coronary heart disease: the ARIC study.
Lamprea-Montealegre JA; Sharrett AR; Matsushita K; Selvin E; Szklo M; Astor BC
Atherosclerosis; 2014 May; 234(1):42-6. PubMed ID: 24607852
[TBL] [Abstract][Full Text] [Related]
18. [Predictive value of plasma apolipoprotein B in myocardial infarction in young subjects. Correlations with coronarographic data].
Douste-Blazy P; Solera ML; Delay M; De Graeve J; Valdiguie P; Marco J; Bernadet P
Arch Mal Coeur Vaiss; 1984 Jan; 77(1):21-6. PubMed ID: 6422890
[TBL] [Abstract][Full Text] [Related]
19. Lipoprotein(a) levels are increased in healthy young subjects with parental history of premature myocardial infarction.
Gaeta G; Cuomo S; Capozzi G; Foglia MC; Barra S; Madrid A; Stornaiuolo V; Trevisan M
Nutr Metab Cardiovasc Dis; 2008 Sep; 18(7):492-6. PubMed ID: 17962002
[TBL] [Abstract][Full Text] [Related]
20. Apolipoproteins A-I and B-markers in coronary risk evaluation.
Agoston-Coldea L; Zdrenghea D; Pop D; Crăciun A; Rusu ML; Mocan T
Rom J Intern Med; 2007; 45(3):251-8. PubMed ID: 18333357
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
